FATE Competitors
Fate Therapeutics, Inc.
$1.93
-$0.01(-0.77%)
40
Overall
60
Value
20
Tech
42
Quality
Market Cap
$232.45M
Volume
1.16M
52W Range
$0.95 - $3.23
Target Price
$5.74
FATE competitors: SRPT, BDX, PTCT, RNA, NBIX. Fate Therapeutics, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
FATE Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics, Inc. | $17.79 | $1.78B | $3.27 | - | 50 |
| BDX Becton, Dickinson and Company | $193.76 | $51.45B | $12.67 | 2.17% | 71 |
| PTCT PTC Therapeutics, Inc. | $60.99 | $4.98B | $1.19 | - | 45 |
| RNA Atrium Therapeutics, Inc. | $7.82 | $131.37M | $-5.08 | - | 20 |
| NBIX Neurocrine Biosciences, Inc. | $137.24 | $13.82B | $7.26 | - | 53 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.93 | -0.8% | 1.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |